[HTML][HTML] Discovery of SARS-CoV-2 Nsp14 and Nsp16 methyltransferase inhibitors by high-throughput virtual screening
R Bobrovs, I Kanepe, N Narvaiss, L Patetko, G Kalnins… - Pharmaceuticals, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening.
R Bobrovs, I Kanepe, N Narvaiss, L Patetko… - Pharmaceuticals …, 2021 - europepmc.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
R Bobrovs, I Kanepe, N Narvaiss… - Pharmaceuticals …, 2021 - pubmed.ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
[PDF][PDF] Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
R Bobrovs, I Kanepe, N Narvaiss, L Patetko… - … - pdfs.semanticscholar.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
[PDF][PDF] Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
R Bobrovs, I Kanepe, N Narvaiss, L Patetko, G Kalnins… - Pharmaceuticals - academia.edu
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
[HTML][HTML] Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
R Bobrovs, I Kanepe, N Narvaiss, L Patetko… - …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening.
R Bobrovs, I Kanepe, N Narvaiss… - Pharmaceuticals …, 2021 - search.ebscohost.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
R Bobrovs, I Kanepe, N Narvaiss, L Patetko… - …, 2021 - search.proquest.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses mRNA capping to
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …
evade the human immune system. The cap formation is performed by the SARS-CoV-2 …